Mergers & Acquisitions, Drugs Industry | featured news

CVS Caremark Corp. says it will pay $1.25 billion to Universal American Corp. for its Medicare prescription drug services unit.

J&J agreed to buy an 18.4% stake in Elan for $1 billion and acquire the rights to much of the Irish biotech company's research into drugs for Alzheimer's disease.

Deal talks between Genentech and Roche hit a snag over dueling interpretations of arcane SEC rules, but the problem is unlikely to derail the transaction, according to people familiar with the matter.

Dow Chemical and Rohm & Haas have reached a tentative deal to complete their disputed $15 billion merger, according to people briefed on the situation.

Drugmakers Merck & Co. and Schering-Plough Corp. are planning to merge under the name Merck in a stock-and-cash deal worth about $41.1 billion.

Swiss drug company Roche Holding increased its offer to acquire the rest of Genentech to $93 a share from $86.50.